Price Chart

Profile

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and immune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.
URL https://www.fatetherapeutics.com
Investor Relations URL https://ir.fatetherapeutics.com/
HQ State/Province California
Sector Healthcare
Industry Biotechnology
Equity Style Small Cap/Growth
Next Earnings Release Feb. 26, 2024
Last Earnings Release Nov. 08, 2023
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and immune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.
URL https://www.fatetherapeutics.com
Investor Relations URL https://ir.fatetherapeutics.com/
HQ State/Province California
Sector Healthcare
Industry Biotechnology
Equity Style Small Cap/Growth
Next Earnings Release Feb. 26, 2024
Last Earnings Release Nov. 08, 2023
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A